Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
/in Dendritic Cells, Glioblastoma, International Publications /von 2004-07-15 / Cancer Res. 2004 Jul;64(14):4973-9Autologous dendritic cell vaccines for non-small-cell lung cancer
/in Dendritic Cells, International Publications, NSCLC /von 2004-07-15 / J. Clin. Oncol. 2004 Jul;22(14):2808-15Vaccination with hybrids of tumor and dendritic cells induces tumor-specific T-cell and clinical responses in melanoma stage III and IV patients
/in International Publications, Malignant Melanoma /von 2004-07-10 / Int. J. Cancer 2004 Jul;110(5):730-40Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2004-07-01 / Leuk. Lymphoma 2004 Jul;45(7):1419-28Dendritic cells, T-cell infiltration, and Grp94 expression in cholangiocellular carcinoma
/in Gallbladder Cancer, International Publications /von 2004-07-01 / Hum. Pathol. 2004 Jul;35(7):881-6
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution